Pulmonology Consultation is Essential; Hematology/Oncology and Infectious Disease as Needed
For bilateral hilar and mediastinal lymphadenopathy with a differential of viral etiology versus malignancy, you should immediately consult Pulmonology for tissue diagnosis via EBUS-TBNA, with concurrent or sequential consultation to Hematology/Oncology if malignancy is suspected and Infectious Disease if infectious etiologies (particularly tuberculosis) remain in the differential.
Primary Consultation: Pulmonology
Pulmonology should be your first consultation because they perform endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), which is the cornerstone diagnostic modality for mediastinal lymphadenopathy 1. This procedure has an 87% diagnostic yield with minimal complications (<0.1%) 2. The timing matters: most providers refer for EBUS-TBNA when lymph nodes reach 11-15 mm, though some consider it at 10 mm 3.
The diagnostic imperative is clear: while 85% of bilateral hilar lymphadenopathy cases turn out to be sarcoidosis, 1.9% represent alternative diagnoses—and critically, 38% of those alternatives are tuberculosis and 25% are lymphoma 2. You cannot afford to miss these.
Secondary Consultations Based on Clinical Context
Hematology/Oncology Consultation When:
- CT characteristics suggest malignancy: unilateral or asymmetric distribution, irregular margins, heterogeneous density, or compression of adjacent structures 4
- Patient has risk factors for malignancy: smoking history, age >50, constitutional symptoms beyond fever
- Extrathoracic lymphadenopathy is present: this suggests systemic disease including lymphoma or metastatic disease 5
Lymphoma and metastatic disease account for significant proportions of mediastinal lymphadenopathy (5% and 22.5% respectively in recent series) 4.
Infectious Disease Consultation When:
- Tuberculosis exposure history exists 6, 7
- Patient has risk factors: immunosuppression, endemic area exposure, HIV
- Imaging shows necrotic or heterogeneous lymph nodes: TB can present with caseating granulomas and may mimic malignancy with mass-like consolidation 7
- Viral etiologies need specialized workup: though most viral lymphadenopathy is self-limited, certain viral infections (EBV, HIV) require specific management 8
Critical Pitfalls to Avoid
Do not assume sarcoidosis without tissue diagnosis unless the patient has pathognomonic clinical syndromes (Löfgren's syndrome, lupus pernio, or Heerfordt's syndrome) 2. Even then, the guideline only suggests not sampling in these specific high-probability scenarios.
Do not rely on PET-CT for initial evaluation: 67.7% of providers appropriately avoid PET-CT for initial workup of isolated thoracic lymphadenopathy 3. CT chest is the preferred initial imaging modality 5.
Do not delay tissue diagnosis in the setting of your differential: with "viral versus malignancy" as your stated differential, you cannot observe and wait. The 11% nondiagnostic sampling rate means some patients need repeat procedures 2.
Algorithmic Approach
Step 1: Consult Pulmonology immediately for EBUS-TBNA consideration
Step 2: Review CT characteristics:
- Bilateral, symmetric, regular margins, homogeneous → likely sarcoidosis but still needs tissue
- Unilateral, asymmetric, irregular margins, heterogeneous → high suspicion for malignancy → add Hematology/Oncology
- Necrotic nodes, TB exposure → add Infectious Disease
Step 3: If EBUS-TBNA is nondiagnostic (11% of cases), Pulmonology can proceed to mediastinoscopy (98% diagnostic yield) 2
Step 4: Definitive pathology guides subsequent specialist involvement—granulomas to Pulmonology ± Infectious Disease, lymphoma to Hematology/Oncology, metastatic disease to Medical Oncology
The evidence strongly supports tissue diagnosis as the standard of care rather than empiric treatment or prolonged observation, particularly when malignancy remains in your differential 1, 4.